Etablert
2020
Hovedkontor
Oslo
ONCOSYNE AS
Our vision is to provide game-changing functional diagnostic tools that give cancer patients significantly better and longer lives. Our clinical-stage technology platform is undergoing evaluation in an ongoing performance study.
In brief, we cultivate the patient’s own living cancer cells and test them against an array of clinically relevant drugs and drug combinations. The product is a diagnostic report that identifies both which cancer drugs are likely to be efficacious and which are not. The test will be marketed as a therapeutic decision tool towards pharmaceutical industry, medical laboratories, and public and private hospitals.
Ingen har gjort krav på denne bedriften enda.
